Australian Red Cross Lifeblood Company Research Report

Company Overview

Name and Mission

• Name: Australian Red Cross Lifeblood

• Mission: Providing life-giving donations for life-changing outcomes. Lifeblood is committed to providing life-giving biological products and support the everyday wellbeing of all Australians.

Foundation and Key People

• Founded: Over 90 years ago, the exact founding date is not specified.

• Founders: Not specified.

• Key People: No specific names of executives or board members are provided, but they are led by a team of executives under the governance of the Lifeblood Board.

Headquarters

• Location: No information is available on the specific headquarters.

Employees and Revenue

• Number of Employees: Approximately 3,500 employees and over 1,000 non-donor volunteers.

• Revenue: No information is available.

Recognition

• What the Company is Known For: Lifeblood is recognized for being a trusted not-for-profit health service provider, contributing significantly to blood, plasma, breast milk donations and transplants benefitting health outcomes across Australia.

Products

Overview of Products

Lifeblood offers a range of life-saving biological products and services:

1. Blood Donation: Lifeblood facilitates more than 1.6 million blood donations annually, saving countless lives through its donation infrastructure.

• Key Features: Blood is collected from donors, tested, and distributed efficiently.

2. Plasma Donation: Plasma is a critical resource for many treatments, and the organization leverages its collection capabilities for various applications.

• Key Features: The plasma is processed and utilized in ways that treat immune deficiencies and blood disorders.

3. Breast Milk Donation: Started in 2018, this program provides donated breast milk for premature babies.

• Key Features: Safe, reliable supply of breast milk, pasteurization and distribution to neonatal units.

4. Organ and Tissue Donation: Working with DonateLife, Lifeblood assists in organ and tissue matching and transplantation support.

• Key Features: Infrastructure and resources ensure efficient data management and matching.

5. Microbiome Products: Recently approved life-changing donor stool products for treating bowel infections.

• Key Features: Therapeutic Goods Administration approved, offering Faecal Microbiota Transplants for patients suffering from Clostridioides difficile infections.

6. Blood Stem Cells: Support for the Australian Bone Marrow Donor Registry, including paperwork processing and tissue typing.

• Key Features: Donor matching initiatives.

Recent Developments

1. New Products:

• Microbiome Product Approval: Lifeblood’s donor stool product received Therapeutic Goods Administration (TGA) approval for use in treating potentially life-threatening bowel infections.

2. New Initiatives:

• Lifeblood encourages donations from people with haemochromatosis, possibly increasing contributions to the national blood supply.

• New campaigns for plasma donations from haemochromatosis patients, with 15,000 existing donors making 37,000 annual donations.

3. Partnerships:

• Collaboration with organizations like the Royal Australian College of General Practitioners and Haemochromatosis Australia to promote blood donation from people with genetic conditions.

4. Technology and Innovations:

• Development of an app for managing donation appointments.

• Joint initiatives with Curtin University to create an orally administered FMT capsule.

Overall, Lifeblood continues to explore innovative measures to improve public health outcomes through blood services, while enriching their capacity to engage donors and optimize their services for a broader impact on Australian healthcare.